Case Series: Exposure to Glucagon-like Peptide-1 Receptor Agonist in the First Trimester of Pregnancy in Two Siblings
CONCLUSION: This report contributes to our knowledge of fetal exposure to exenatide. Large-scale randomized studies are needed for its safe use in pregnancy.PMID:37937565 | DOI:10.2174/0118715303252109231023115112
Source: Endocrine, Metabolic and Immune Disorders Drug Targets - Category: Endocrinology Authors: Şerife Ezgi Doğan Şerife Mehlika Kuşkonmaz Gonul Koc Ebru Aypar Cavit Çulha Source Type: research
More News: Atrial Septal Defect | Babies | Byetta | Diabetes | Eating Disorders & Weight Management | Endocrinology | Fatty Liver Disease (FLD) | Hole in the Heart | Liver | Obesity | OBGYN | Ovaries | Polycystic Ovary Syndrome | Pregnancy | Study | Ultrasound | Urology & Nephrology